TRIPLE A INVESTMENTS
Triple A Investments facilitates high-level international funding for Government projects in Africa, Asia, Europe and the Middle East.
In healthcare, our Group establish Molecular Diagnostics for Genetic Diseases and Oncology, providing early detection for cancers.
Triple A Investments & Partners establish Molecular Diagnostics Centre for Genetic Diseases and Oncology, providing early detection for bowel, breast, cervical, lung and prostate cancers.
Molecular Diagnostics facilitates correct treatment, saving valuable time in treatment compared with conventional clinical diagnosis.
Early detection of cancers increases the success of treatment and life expectancy is extended for patients while providing cost savings to the healthcare system.